DENTSPLY SIRONA financials
$8.98−3.23%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.68B | $3.79B | $3.96B | $3.92B | $4.23B | $3.34B | $4.02B | $3.99B | $3.99B | $3.75B |
| Gross profit | $1.84B | $1.96B | $2.09B | $2.13B | $2.35B | $1.66B | $2.16B | $2.07B | $2.19B | $2.00B |
| Gross margin | 50.0% | 51.6% | 52.6% | 54.2% | 55.5% | 49.6% | 53.8% | 51.9% | 54.8% | 53.4% |
| Operating income | -$422.0M | -$879.0M | -$85.0M | -$937.0M | $608.0M | -$3.0M | $353.0M | -$958.0M | -$1.56B | $454.7M |
| Net income | -$598.0M | -$910.0M | -$132.0M | -$950.0M | $411.0M | -$73.0M | $256.0M | -$1.01B | -$1.55B | $429.9M |
| Net margin | −16.3% | −24.0% | −3.3% | −24.2% | 9.7% | −2.2% | 6.4% | −25.4% | −38.8% | 11.5% |
| Diluted EPS | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.87 | $-0.33 | $1.14 | $-4.51 | $-6.76 | $1.94 |
| EBITDA | $604.0M | $537.0M | $632.0M | $692.0M | $971.0M | $565.0M | $757.0M | $680.0M | $830.2M | $749.6M |
| Operating cash flow | $235.0M | $461.0M | $377.0M | $517.0M | $657.0M | $649.0M | $639.0M | $500.0M | $601.9M | $563.4M |
| Free cash flow | $104.0M | $281.0M | $228.0M | $368.0M | $515.0M | $562.0M | $516.0M | $317.0M | $457.6M | $438.4M |
| Diluted shares | 199.4M | 203.2M | 212.0M | 215.5M | 220.2M | 219.2M | 224.4M | 224.3M | 229.4M | 221.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $326.0M | $272.0M | $334.0M | $365.0M | $339.0M | $438.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $2.33B | $2.13B | $2.12B | $1.94B | $2.10B | $2.28B |
| Total assets | $5.43B | $5.75B | $7.37B | $7.64B | $9.24B | $9.35B |
| Total liabilities | $4.09B | $3.81B | $4.08B | $3.83B | $4.24B | $4.42B |
| Shareholders' equity | $1.34B | $1.94B | $3.29B | $3.81B | $5.00B | $4.93B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology